NEW YORK (Thomson Financial) - Pfizer Inc. Monday said 86.8% of Encysive
Pharmaceuticals Inc. common shares were tendered pursuant to Pfizer's tender
offer, through its subsidiary Explorer Acquisition Corp., of $2.35 a share in
cash.
Pfizer also said Explorer has commenced an offering period to acquire all
remaining untendered shares that will expire at 5:00 p.m. ET on Monday.
Pfizer shares closed at $21.35 on Friday. Encysive shares closed at $2.34.
Christie Rizk
cr/tk1
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|